- Nachrichtendetail
-
26.04.2024 15:02:59 - dpa-AFX: *AMGEN TO SUBMIT MAA TO EMA FOR TEPROTUMUMAB IN THYROID EYE DISEASE TREATMENT
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
AMGEN INC. DL-,0001 | 867900 | Frankfurt | 288,400 | 16.05.24 19:40:19 | -5,300 | -1,80% | 0,000 | 0,000 | 292,000 | 293,700 |
